Disagree. They are not a long way off. They are already generating more revenue then some other cannabis stocks on the ASX.
IHL is massively undervalued. Trials start soon - excellent agreement made with the trials also. They are setting themselves up well with large names so when the trials are over its go go go. If you don't get on this soon, it would be a missed opportunity imo.
- Forums
- ASX - By Stock
- IHL
- Ann: CEO Update on Cannvalate collaboration and sales
Ann: CEO Update on Cannvalate collaboration and sales, page-33
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)